Safety of Withdrawing Inhaled Nitric Oxide Therapy in Persistent Pulmonary Hypertension of the Newborn
Authors:
- Dennis DavidsonDDDennis Davidson
- the I-NO/PPHN Study GroupTGthe I-NO/PPHN Study Group
- 1 August 1999
- journal article
- clinical trial
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 104 (2) , 231-236
Abstract
Objective.: Because of case reports describing hypoxemia on withdrawal of inhaled nitric oxide (I-NO), we prospectively examined this safety issue in newborns with persistent pulmonary hypertension who were classified as treatment successes or failures during a course of I-NO therapy.Methods.: Randomized, placebo-controlled, double-masked, dose-response clinical trial at 25 tertiary centers from April 1994 to June 1996. Change in oxygenation and outcome (death and/or extracorporeal membrane oxygenation) during or immediately after withdrawing I-NO were the principal endpoints. Patients (n = 155) were term infants, <3 days old at study entry with echocardiographic evidence of persistent pulmonary hypertension of the newborn. Exclusion criteria included previous surfactant treatment, high-frequency ventilation, or lung hypoplasia. Withdrawal from treatment gas (0, 5, 20, or 80 ppm) started once treatment success or failure criteria were met. Withdrawal of treatment gas occurred at 20% decrements at <4 hours between steps.Results.: The patient profile was similar for placebo and I-NO groups. Treatment started at an oxygenation index (OI) of 25 ± 10 (mean ± SD) at 26 ± 18 hours after birth. For infants classified as treatment successes (mean duration of therapy = 88 hours, OI <10), decreases in the arterial partial pressure of oxygen (Pao2) were observed only at the final step of withdrawal. On cessation from 1, 4, and 16 ppm, patients receiving I-NO demonstrated a dose-related reduction in Pao2 (−11 ± 23, −28 ± 24, and −50 ± 48 mm Hg, respectively). For infants classified as treatment failures (mean duration of therapy = 10 hours), no change in OI occurred for the placebo group (−13 ± 36%, OI of 31 ± 11 after the withdrawal process); however a 42 ± 101% increase in OI to 46 ± 21 occurred for the pooled nitric oxide doses. One death was possibly related to withdrawal of I-NO.Conclusion.: For infants classified as treatment successes, a dose response between the I-NO dose and decrease in Pao2 after discontinuing I-NO was found. A reduction in I-NO to 1 ppm before discontinuation of the drug seems to minimize the decrease in Pao2 seen. For infants failing treatment, discontinuation of I-NO could pose a life-threatening reduction in oxygenation should extracorporeal membrane oxygenation not be readily available or I-NO cannot be continued on transport.Keywords
This publication has 15 references indexed in Scilit:
- Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart diseaseThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Inhaled Nitric Oxide for the Early Treatment of Persistent Pulmonary Hypertension of the Term Newborn: A Randomized, Double-Masked, Placebo-Controlled, Dose-Response, Multicenter StudyPediatrics, 1998
- Diagnoses Associated with the Delivery of Mechanical Ventilation in the Newborn † 1199Pediatric Research, 1997
- Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the NewbornNew England Journal of Medicine, 1997
- Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory FailureNew England Journal of Medicine, 1997
- Life-Threatening Effects of Discontinuing Inhaled Nitric Oxide in Severe Respiratory FailureAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newbornThe Journal of Pediatrics, 1995
- Expression of Endothelin-1 in the Lungs of Patients with Pulmonary HypertensionNew England Journal of Medicine, 1993
- Hidden mortality rate associated with extracorporeal membrane oxygenationThe Journal of Pediatrics, 1990
- Acute Respiratory Failure in the AdultNew England Journal of Medicine, 1972